Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The influence of domestic manufacturing capabilities on biologic pricing in emerging economies

An Author Correction to this article was published on 01 November 2019

This article has been updated

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Affordability of biologics across various emerging economies.
Fig. 2: Average drug prices of various classes of biologics from 2007 to 2017 in emerging markets (India, China, Republic of Korea, Nigeria and South Africa).

Change history

  • 01 November 2019

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.


  1. McKinsey. Biosimilars seven years on: where are we and what’s next? (2013).

  2. Gross, H. J. & Vietri, F. Barriers to Biologic Therapy Use for Autoimmune Disorders in Emerging Markets, International Society for Pharmacoeconomics and Outcomes Research: 16th Annual European Conference (2013).

  3. Ghosh, A., Ray, S., Dewan, S., Shah, K. & Sahani, K. Indian Pharmaceutical Sector (ICRA Ltd., New Delhi, 2012).

    Google Scholar 

  4. Pharmaceutical Export Promotion Council of India. 11th Annual Report, 2014–2015 (Government of India, Bangalore, India, 2015).

    Google Scholar 

  5. Edney, A. & Mittelman, M. Valeant, Turing would face subpoena vote under Democrat’s plan. Bloomberg (4 November 2015).

  6. Kateja, N., Agarwal, H., Hebbi, V. & Rathore, A. S. Biotechnol. Prog. 33, 998–1009 (2017).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Anurag S. Rathore.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rathore, A.S., Shereef, F. The influence of domestic manufacturing capabilities on biologic pricing in emerging economies. Nat Biotechnol 37, 498–501 (2019).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research